30 November 2009 – LawFuel.com – Davis Polk & Wardwell LLP advised Warner Chilcott plc in connection with an SEC-registered offering of 23,000,000 of its ordinary shares by certain selling shareholders for an aggregate price to the public of approximately $512 million. The selling shareholders included funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the company’s senior management. The ordinary shares are listed on Nasdaq.
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the gastroenterology, women’s healthcare, dermatology and urology segments of the U.S. and Western European pharmaceuticals markets. The company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products.
The Davis Polk corporate team included partner Michael Kaplan and associates Sophia Hudson, Y. Jung Choi, Miya C. Kang and Joel Pulliam. Partner Michael Mollerus and associates Craig A. Phillips and Adam B. Perry provided tax advice. Catherine L. Martin provided 1940 Act advice. Amarilys Katy Barbosa was the legal assistant on the transaction. All members of the Davis Polk team are based in the New York office.
